| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 2 May 2024 | 24 Apr 2024 |
| ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended 31st March 2024 after these results are reviewed by the Audit Committee. Please find enclosed outcome of Board Meeting held on 2nd May, 2024 Please find attached Audited Financial Results for the Quarter and Financial Year ended March 31, 2024 Please find enclosed intimation of resignation of Chief Financial Officer with effect from the closure of business hours on 3rd May, 2024 Please find enclosed intimation of resignation of Mr. Vijay K. Khot, Independent Director of the Company with effect from closure of business hours on 2nd May, 2024 Please find enclosed the intimation of cessation of Directorship of Mr. Vijay K. Khot, Independent Director of the Company, with effect from the closure of business hours on 2nd May, 2024. The 30th (Thirtieth) Annual General Meeting of the Company will be held on Monday, 29th July, 2024, at 4.00 p.m. (IST) by Video Conference / Other Audio Visual Mode. (As Per BSE Announcement Dated on 02/05/2024) | ||
| Board Meeting | 25 Jan 2024 | 12 Jan 2024 |
| ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) that the Meeting of the Board of Directors of Astec LifeSciences Limited (the Company) is scheduled to be held on Thursday 25th January 2024 to inter alia consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months period ended 31st December 2023 after these results are reviewed by the Audit Committee. Kindly find enclosed the Outcome of the Board Meeting held by Astec LifeSciences Limited on January 25, 2024. Kindly find enclosed the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months period ended December 31, 2023 approved in the Board Meeting held by Astec LifeSciences Limited on January 25, 2024. Re-appointment of Mr. Anurag Roy as the Whole Time Director & Chief Executive Officer of the Company, subject to the approval of the Shareholders. (As per BSE Announcement Dated on 25/01/2024) | ||
| Board Meeting | 27 Oct 2023 | 10 Oct 2023 |
| ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 that the Meeting of the Board of Directors of Astec LifeSciences Limited (the Company) is scheduled to be held on Friday 27th October 2023 to inter alia consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Half Year ended 30th September 2023 after these results are reviewed by the Audit Committee and the Board of Directors may also consider and approve enhancement in the existing limit of issuance of Debenture(s) or Debt Securities upto such limit as may be deemed appropriate by the Board subject to such other approval(s) as may be applicable. Kindly find enclosed Outcome of Board Meeting held on October 27, 2023 Please find enclosed outcome of Board Meeting held on October 27, 2023 (As Per BSE Announcement Dated on 27.10.2023) kindly find enclosed the copies of the newspaper publications of the unaudited financial results for the quarter and Half Year ended September 30, 2023. (As per BSE Announcement Dated on 28/10/2023) | ||
| Board Meeting | 27 Jul 2023 | 20 Jul 2023 |
| ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) that the Meeting of the Board of Directors of Astec LifeSciences Limited (the Company) is scheduled to be held on Thursday 27th July 2023 to inter alia consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter ended 30th June 2023 after these results are reviewed by the Audit Committee. Pursuant to Regulation 30, 33 and 52(4) of the SEBI Listing Regulations, this is to inform you that the Board of Directors of Company at its Meeting held today, i.e. July 27, 2023 has approved the Unaudited Financial Results along with the noting of the Limited Review Report of the Statutory Auditor. Kindy find enclosed the Outcome of the Board Meeting held by the Astec LifeSciences Limited on July 27, 2023. (As per BSE Announcement Dated on 27/07/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
